M. Ohno

848 total citations
34 papers, 734 citations indexed

About

M. Ohno is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, M. Ohno has authored 34 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Physiology and 9 papers in Organic Chemistry. Recurrent topics in M. Ohno's work include Adenosine and Purinergic Signaling (10 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). M. Ohno is often cited by papers focused on Adenosine and Purinergic Signaling (10 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). M. Ohno collaborates with scholars based in Japan, United States and Czechia. M. Ohno's co-authors include Kenneth A. Jacobson, T. Kendall Harden, Yasuyuki Endo, Koichi Shudo, Akiko Itai, Susanna Tchilibon, Masaaki Hirano, Bhalchandra V. Joshi, Savitri Maddileti and Pedro Besada and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

M. Ohno

32 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Ohno Japan 14 411 296 224 85 74 34 734
Pedro Besada Spain 20 439 1.1× 404 1.4× 388 1.7× 61 0.7× 76 1.0× 50 964
Elfatih Elzein United States 20 412 1.0× 340 1.1× 286 1.3× 146 1.7× 91 1.2× 28 849
Aliaa Abdelrahman Germany 21 442 1.1× 657 2.2× 246 1.1× 64 0.8× 108 1.5× 38 1.0k
Iain G. Dougall United Kingdom 17 528 1.3× 119 0.4× 98 0.4× 103 1.2× 229 3.1× 29 939
Anthony H. Ingall United Kingdom 12 240 0.6× 356 1.2× 170 0.8× 173 2.0× 74 1.0× 14 789
E.A. van Schaick Netherlands 13 246 0.6× 192 0.6× 37 0.2× 38 0.4× 96 1.3× 17 575
Silvia Paoletta United States 23 1.1k 2.6× 775 2.6× 357 1.6× 111 1.3× 440 5.9× 42 1.6k
Aishe Chen United States 10 579 1.4× 415 1.4× 109 0.5× 26 0.3× 216 2.9× 13 748
Meryem Köse Germany 16 349 0.8× 205 0.7× 210 0.9× 20 0.2× 136 1.8× 25 641
Elizabeth A. Vecchio Australia 11 428 1.0× 305 1.0× 63 0.3× 52 0.6× 161 2.2× 13 589

Countries citing papers authored by M. Ohno

Since Specialization
Citations

This map shows the geographic impact of M. Ohno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ohno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ohno more than expected).

Fields of papers citing papers by M. Ohno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ohno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ohno. The network helps show where M. Ohno may publish in the future.

Co-authorship network of co-authors of M. Ohno

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ohno. A scholar is included among the top collaborators of M. Ohno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ohno. M. Ohno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohno, M., Hideki Inoue, Hiroyuki Meguro, et al.. (2012). Design and synthesis of novel p38α MAP kinase inhibitors: Discovery of pyrazole-benzyl ureas bearing 2-molpholinopyrimidine moiety. Bioorganic & Medicinal Chemistry Letters. 22(15). 5118–5122. 13 indexed citations
2.
Ohno, M., et al.. (2010). TRA-418, a thromboxane A2 receptor antagonist and prostacyclin receptor agonist, inhibits platelet-leukocyte interaction in human whole blood. Thrombosis and Haemostasis. 104(10). 788–795. 9 indexed citations
3.
4.
Ohno, M., et al.. (2005). Development of 3,4-dihydro-2H-benzo[1,4]oxazine derivatives as dual thromboxane A2 receptor antagonists and prostacyclin receptor agonists. Bioorganic & Medicinal Chemistry. 14(6). 2005–2021. 18 indexed citations
5.
Jacobson, Kenneth A., M. Ohno, Heng T. Duong, et al.. (2005). A Neoceptor Approach to Unraveling Microscopic Interactions between the Human A2A Adenosine Receptor and Its Agonists. Chemistry & Biology. 12(2). 237–247. 37 indexed citations
6.
Jacobson, Kenneth A., Stefano Costanzi, M. Ohno, et al.. (2004). Molecular Recognition at Purine and Pyrimidine Nucleotide (P2) Receptors. Current Topics in Medicinal Chemistry. 4(8). 805–819. 46 indexed citations
7.
Ohno, M., Stefano Costanzi, Hak Sung Kim, et al.. (2004). Nucleotide analogues containing 2-oxa-bicyclo[2.2.1]heptane and l-α-threofuranosyl ring systems: interactions with P2Y receptors. Bioorganic & Medicinal Chemistry. 12(21). 5619–5630. 30 indexed citations
8.
Cattaneo, Marco, Anna Lecchi, M. Ohno, et al.. (2004). Antiaggregatory activity in human platelets of potent antagonists of the P2Y1 receptor. Biochemical Pharmacology. 68(10). 1995–2002. 82 indexed citations
9.
Ohno, M., Zhan‐Guo Gao, Philippe Van Rompaey, et al.. (2004). Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position. Bioorganic & Medicinal Chemistry. 12(11). 2995–3007. 42 indexed citations
10.
11.
Yamada, Naohiro, et al.. (2003). Effects of TRA‐418, a novel TP‐receptor antagonist, and IP‐receptor agonist, on human platelet activation and aggregation. British Journal of Pharmacology. 140(5). 889–894. 10 indexed citations
12.
Ohno, M., Masato Okada, & Kunihiko Fukushima. (1995). Neocognitron learning by backpropagation. Systems and Computers in Japan. 26(5). 19–28. 3 indexed citations
13.
Shimohigashi, Yoshinobu, et al.. (1993). Receptor-Mediated Specific Biological Activity of a β-Amyloid Protein Fragment for NK-1 Substance P Receptors. Biochemical and Biophysical Research Communications. 193(2). 624–630. 16 indexed citations
14.
Kobayashi, Shunsuke, et al.. (1992). Molecular design of biologically active compounds based on platelet activating factor (PAF): 7-oxabicyclo(2.2.1)heptane system as a strong antagonist of PAF.. Chemical and Pharmaceutical Bulletin. 40(10). 2891–2893. 1 indexed citations
15.
Kinoshita, Noriaki, M. Ohno, Tetsuo Nishiura, et al.. (1991). Glycosylation at the Fab portion of myeloma immunoglobulin G and increased fucosylated biantennary sugar chains: structural analysis by high-performance liquid chromatography and antibody-lectin enzyme immunoassay using Lens culinaris agglutinin.. PubMed. 51(21). 5888–92. 37 indexed citations
16.
Ohno, M., Shun Ishibashi, Kazuwa Nakao, et al.. (1989). A neonatal case of apolipoprotein C-II deficiency. European Journal of Pediatrics. 148(6). 550–552. 4 indexed citations
17.
Kanazawa, K, et al.. (1983). [Inhibitory effects of OK-432 and PSK on cell growth of in vitro human choriocarcinoma cell lines].. PubMed. 10(10). 2217–24. 1 indexed citations
18.
Takaishi, Kiyomi, et al.. (1980). 263. Immunological Studies on Quantitative and Qualitative Changes of Peripheral Blood Lymphocytes in Pregnant Women. 日本産科婦人科學會雜誌. 32(12). 2183–2184. 1 indexed citations
19.
Ohno, M., H Nakata, & Kazuo Matsuura. (1980). Enhancement of metastatic pulmonary malignant lymphoma following lung irradiation.. PubMed. 40(12). 1183–8. 3 indexed citations
20.
Ohyama, Akio, et al.. (1964). [TISSUE CULTURE STUDIES ON JAPANESE B ENCEPHALITIS VIRUS. IV. VIRAL GROWTH CURVES IN HUMAN TISSUE CULTURES].. PubMed. 38. 124–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pedro Besada Breakdown of academic impact, for papers by Elfatih Elzein Breakdown of academic impact, for papers by Aliaa Abdelrahman Breakdown of academic impact, for papers by Iain G. Dougall Breakdown of academic impact, for papers by Anthony H. Ingall Breakdown of academic impact, for papers by E.A. van Schaick Breakdown of academic impact, for papers by Silvia Paoletta Breakdown of academic impact, for papers by Aishe Chen Breakdown of academic impact, for papers by Meryem Köse Breakdown of academic impact, for papers by Elizabeth A. Vecchio
Rankless by CCL
2026